From Our Partners
Friday, June 24, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Notable Contracts: Illumina Reagents for CDC Laboratories

by Global Biodefense Staff
July 27, 2016
Notable CBRN Contracts

The U.S. Centers for Disease Control and Prevention (CDC) has awarded a new Indefinite Delivery/Indefinite Quantity (IDIQ) Blanket Purchase Agreement to lllumina to acquire an assortment of next generation library preparation and sequencing consumables.

The action supports several CDC programs which currently own and operate the lllumina HiSeq, MiSeq and NextSeq Next Generation Sequencing Instruments to support their Advanced Molecular Detection (AMO) research needs.

This BPA will allow lllumina next generation sequencing (NGS) reagents and supplies to be ordered on a VISA purchase up to $25,000. “As CDC increases its commitment to develop new AMO tools to support the CDC mission there will be an increase in the procurement of AMO reagents and supplies over the next few years,” states the announcement. “This will reduce the burden on the lab branch staff and the administrative staff in PGO and OCFO. This BPA will represent the best value to the government because it will provide a mechanism for more consolidated purchasing, for better pricing, for more efficient and timely purchasing, and will reduce the administrative burden.”

The overall contract has as a cost ceiling of $5,000,000 for year one and up to $25,000,000 over the course of the agreement from Jan 2016 – Dec 2020.

Source: FBO.gov

From Our Partners
Tags: Awards

Related Posts

Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Biodefense Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC